Published in Gene Therapy Weekly, November 3rd, 1997
Researchers C. Rancourt and colleagues from the University of Alabama, Birmingham, Alabama, examined the feasibility of using HUVEC as vehicles for delivery toxin gene products to tumor sites. They presented in vitro and in vivo results at the 3rd European Conference on Gene Therapy of Cancer, held September 11-13, 1997, in Berlin, Germany ("Human Endothelial Cells as Cellular Vehicles for Ovarian Cancer Gene Therapy").
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.